Bonus & Incentive Agreements in the Pharmaceuticals Industry
2,337 Contracts & Agreements
- 60 DEGREES PHARMACEUTICALS, INC. (2 contracts)
- Acasti Pharma Inc. (1)
- ACELRX PHARMACEUTICALS INC (19)
- Acer Therapeutics Inc. (10)
- ACHILLION PHARMACEUTICALS INC (7)
- Aclaris Therapeutics, Inc. (5)
- Acreage Holdings, Inc. (4)
- ACURA PHARMACEUTICALS, INC (2)
- Adamis Pharmaceuticals Corp (14)
- ADIAL PHARMACEUTICALS, INC. (8)
- Aegerion Pharmaceuticals, Inc. (6)
- AEON Biopharma, Inc. (6)
- AERIE PHARMACEUTICALS INC (6)
- Aerpio Pharmaceuticals, Inc. (10)
- AGILE THERAPEUTICS INC (5)
- Akers Biosciences, Inc. (8)
- Akorn (6)
- ALDER BIOPHARMACEUTICALS INC (9)
- Alexza Pharmaceuticals Inc. (9)
- ALGORX PHARMACEUTICALS INC (1)
- ALIMERA SCIENCES INC (18)
- Allergan, plc (9)
- ALSERES PHARMACEUTICALS INC (2)
- Altus Pharmaceuticals Inc. (3)
- Amag Pharmaceuticals (20)
- Amneal Pharmaceuticals, Inc. (6)
- Amphastar Pharma (3)
- Ampio Pharmaceuticals, Inc. (4)
- AMYLIN PHARMACEUTICALS INC (7)
- Amylyx Pharmaceuticals, Inc. (3)
- AN2 Therapeutics, Inc. (5)
- Anacor Pharmaceuticals, Inc. (9)
- Anebulo Pharmaceuticals, Inc. (2)
- Angion Biomedica Corp. (11)
- ANI Pharma Inc (22)
- Anthera Pharmaceuticals Inc (7)
- APP Pharmaceuticals, Inc. (1)
- APRICUS BIOSCIENCES, INC. (4)
- Aquestive Therapeutics, Inc. (5)
- Aralez Pharmaceuticals Inc. (11)
- ARIAD PHARMACEUTICALS INC (11)
- Arog Pharmaceuticals, Inc. (1)
- ARTELO BIOSCIENCES, INC. (2)
- ARVINAS, INC. (7)
- Assertio Holdings, Inc. (5)
- Assertio Therapeutics, Inc (22)
- ATAI Life Sciences B.V. (6)
- Atea Pharmaceuticals, Inc. (6)
- Athira Pharma, Inc. (9)
- Auspex Pharmaceuticals, Inc. (6)
- AUXILIUM PHARMACEUTICALS INC (5)
- AVADEL PHARMACEUTICALS PLC (3)
- AVALON PHARMACEUTICALS INC (4)
- AVANIR PHARMACEUTICALS, INC. (7)
- AVENUE THERAPEUTICS, INC. (1)
- Axsome Therapeutics, Inc. (4)
- AYTU BIOSCIENCE, INC (1)
- Bakhu Holdings, Corp. (1)
- Baudax Bio, Inc. (2)
- Bausch Health Companies Inc. (27)
- BENTLEY PHARMACEUTICALS INC (5)
- Bespoke Extracts, Inc. (1)
- Big Rock Partners Acquisition Corp. (1)
- BIODELIVERY SCIENCES INTERNATIONAL INC (14)
- Biofrontera Inc. (5)
- Biohaven Ltd. (1)
- BioPharmX Corp (5)
- Blue Water Acquisition Corp. (2)
- Braeburn Pharmaceuticals, Inc. (1)
- Bristol-Myers Squibb (112)
- CADENCE PHARMACEUTICALS INC (10)
- Cancer Prevention Pharmaceuticals, Inc. (6)
- Cannabics Pharmaceuticals Inc. (1)
- Canopy Growth Corp (9)
- Cara Therapeutics, Inc. (4)
- CARDAX, INC. (1)
- CASSAVA SCIENCES INC (10)
- Catalent Inc (42)
- Celator Pharmaceuticals Inc (1)
- CELGENE CORP (15)
- CERAGENIX PHARMACEUTICALS, INC. (1)
- Cerecor Inc. (6)
- Charlotte's Web Holdings, Inc. (1)
- CHIASMA, INC (2)
- CHINA PHARMA HOLDINGS, INC. (3)
- CinCor Pharma, Inc. (1)
- Cingulate Inc. (3)
- Citius Pharmaceuticals, Inc. (3)
- Clearside Biomedical, Inc. (7)
- Clever Leaves Holdings Inc. (6)
- CLS Holdings USA, Inc. (2)
- Cocrystal Pharma, Inc. (1)
- COGNITION THERAPEUTICS INC (7)
- COLLEGIUM PHARMACEUTICAL, INC (14)
- CoLucid Pharmaceuticals, Inc. (7)
- Columbia Care Inc. (2)
- Context Therapeutics Inc. (3)
- Corcept Therapeutics Incorporated (6)
- CorMedix Inc. (6)
- COSMO VENTURES INC (1)
- CPEX Pharmaceuticals, Inc. (1)
- Cronos Group Inc. (3)
- CUBIST PHARMACEUTICALS INC (29)
- CUMBERLAND PHARMACEUTICALS INC (10)
- Cure Pharmaceutical Holding Corp. (4)
- CymaBay Therapeutics, Inc. (4)
- Cyteir Therapeutics, Inc. (9)
- Dermata Therapeutics, Inc. (5)
- DiCE MOLECULES HOLDINGS, LLC (2)
- Dova Pharmaceuticals Inc. (4)
- EASTON PHARMACEUTICALS INC. (1)
- Edgewise Therapeutics, Inc. (3)
- Egalet Corp (12)
- Elanco Animal Health Inc (9)
- Elixir Pharmaceuticals, Inc. (5)
- Eloxx Pharmaceuticals, Inc. (10)
- ENCYSIVE PHARMACEUTICALS INC (1)
- Endo International plc (39)
- Endo Pharmaceuticals Solutions Inc. (4)
- EPIX Pharmaceuticals, Inc. (6)
- Eton Pharmaceuticals, Inc. (6)
- Evofem Biosciences, Inc. (13)
- Evoke Pharma Inc (5)
- Evolus, Inc. (7)
- Exactus, Inc. (7)
- EYEGATE PHARMACEUTICALS INC (8)
- EYENOVIA, INC. (6)
- EyePoint Pharmaceuticals, Inc. (24)
- EYETECH PHARMACEUTICALS INC (2)
- Foamix Pharmaceuticals Ltd. (3)
- Fulcrum Therapeutics, Inc. (11)
- GB SCIENCES INC (1)
- GENAISSANCE PHARMACEUTICALS INC (2)
- GRAYBUG VISION, INC. (3)
- Green Thumb Industries Inc. (2)
- GUILFORD PHARMACEUTICALS INC (2)
- GW PHARMACEUTICALS PLC (2)
- Harmony Biosciences Holdings, Inc. (7)
- HARROW HEALTH, INC. (11)
- Horizon Pharma plc (13)
- Hoth Therapeutics, Inc. (1)
- IDENIX PHARMACEUTICALS INC (8)
- Ikena Oncology, Inc. (2)
- IMARA Inc. (11)
- INNOVATE BIOPHARMACEUTICALS, INC. (12)
- Innoviva, Inc. (33)
- INSPIRE PHARMACEUTICALS INC (5)
- Intersect ENT, Inc. (10)
- Intra-Cellular Therapies, Inc. (14)
- ISTA PHARMACEUTICALS INC (3)
- Iterum Therapeutics plc (11)
- Jaguar Health, Inc. (5)
- JAVELIN PHARMACEUTICALS, INC (2)
- Jazz Pharmaceuticals plc (66)
- Johnson & Johnson (9)
- JUNIPER PHARMACEUTICALS INC (9)
- Jushi Holdings Inc. (2)
- Kala Pharmaceuticals, Inc. (12)
- Kaleido Biosciences, Inc. (3)
- Kannalife Inc (2)
- Kaya Holdings, Inc. (1)
- KEMPHARM, INC (4)
- KING PHARMACEUTICALS INC (19)
- KOLLTAN PHARMACEUTICALS INC (3)
- KOS PHARMACEUTICALS INC (1)
- Landos Biopharma, Inc. (1)
- Lannett Company, Inc. (1)
- Lexaria Bioscience Corp. (1)
- Lilly (Eli) & Co. (23)
- LIPELLA PHARMACEUTICALS INC (7)
- Lipocine Inc. (5)
- Liquidia Corp (9)
- Liquidia Technologies Inc (1)
- Longboard Pharmaceuticals, Inc. (8)
- Lowell Farms Inc. (1)
- Lumena Pharmaceuticals, Inc. (1)
- Lyra Therapeutics, Inc. (5)
- Mallinckrodt (31)
- MAP Pharmaceuticals, Inc. (2)
- Marijuana Co of America, Inc. (1)
- MARINUS PHARMACEUTICALS INC (16)
- Medicine Man Technologies, Inc. (8)
- MedMen Enterprises, Inc. (1)
- Melt Pharmaceuticals, Inc. (5)
- MEMORY PHARMACEUTICALS CORP (1)
- Menlo Therapeutics Inc. (16)
- Merck (69)
- MiddleBrook Pharmaceuticals, Inc. (1)
- Milestone Pharmaceuticals Inc. (6)
- MILLENNIUM PHARMACEUTICALS INC (2)
- Mind Medicine (MindMed) Inc. (2)
- MIRA PHARMACEUTICALS, INC. (2)
- Molecular Insight Pharmaceuticals, Inc. (2)
- Mylan N.V. (17)
- MYnd Analytics, Inc. (3)
- MyoKardia Inc (4)
- Nabriva Therapeutics plc (13)
- NEKTAR THERAPEUTICS (23)
- Neos Therapeutics, Inc. (2)
- Neuralstem, Inc. (11)
- NEW RIVER PHARMACEUTICALS INC (1)
- NEXIEN BIOPHARMA, INC. (2)
- NGM BIOPHARMACEUTICALS INC (5)
- NovaBay Pharmaceuticals, Inc. (8)
- Novan, Inc. (7)
- NPS PHARMACEUTICALS INC (7)
- NUCRYST Pharmaceuticals Corp. (4)
- OCULAR THERAPEUTIX, INC (13)
- OMEROS CORP (4)
- Omthera Pharmaceuticals, Inc. (2)
- OncoMed Pharmaceuticals Inc (6)
- Onconova Therapeutics, Inc. (4)
- One World Pharma, Inc. (3)
- ONYX PHARMACEUTICALS INC (12)
- OPIANT PHARMACEUTICALS, INC. (6)
- OPTIMER PHARMACEUTICALS INC (5)
- OptiNose, Inc. (7)
- ORAMED PHARMACEUTICALS INC. (4)
- Organon & Co. (3)
- OSCIENT PHARMACEUTICALS CORP (2)
- OSI PHARMACEUTICALS INC (6)
- Osmotica Pharmaceuticals plc (9)
- OTONOMY, INC. (4)
- Pacira Pharmaceuticals, Inc. (14)
- Panacea Acquisition Corp (6)
- PANACOS PHARMACEUTICALS, INC. (4)
- Paratek Pharmaceuticals, Inc. (13)
- PaxMedica, Inc. (5)
- PEAK PHARMACEUTICALS, INC. (1)
- PENWEST PHARMACEUTICALS CO (7)
- Perrigo (43)
- PetLife Pharmaceuticals, Inc. (1)
- Petros Pharmaceuticals, Inc. (3)
- Pfizer (10)
- Phathom Pharmaceuticals, Inc. (11)
- Phibro Animal Health Corporation (3)
- PLIANT THERAPEUTICS, INC. (3)
- PLx Pharma Inc. (5)
- PONIARD PHARMACEUTICALS, INC. (11)
- PRAECIS PHARMACEUTICALS INC (1)
- PREDIX PHARMACEUTICALS HOLDINGS INC (3)
- Prestige Brands Holdings Inc (4)
- Processa Pharmaceuticals, Inc. (2)
- ProPhase Labs, Inc. (3)
- Provention Bio, Inc. (3)
- Pulmatrix, Inc. (6)
- QUANTA INC (1)
- QUARK PHARMACEUTICALS INC (3)
- QUATRX PHARMACEUTICALS CO (1)
- QUESTCOR PHARMACEUTICALS INC (3)
- Ra Pharmaceuticals, Inc. (2)
- RADIENT PHARMACEUTICALS Corp (1)
- Rain Therapeutics Inc. (9)
- Rani Therapeutics Holdings, Inc. (3)
- REATA PHARMACEUTICALS INC (3)
- Recro Pharma, Inc. (9)
- Reliant Pharmaceuticals, Inc. (7)
- RELMADA THERAPEUTICS, INC. (11)
- RespireRx Pharmaceuticals Inc. (16)
- resTORbio, Inc. (19)
- Revance Therapeutics, Inc. (21)
- Rib-X Pharmaceuticals, Inc. (10)
- ROCK CREEK PHARMACEUTICALS, INC. (7)
- Roivant Sciences Ltd. (9)
- Royalty Pharma plc (2)
- Sagent Pharmaceuticals, Inc. (5)
- SALIX PHARMACEUTICALS LTD (1)
- SANCILIO PHARMACEUTICALS COMPANY, INC. (2)
- Satsuma Pharmaceuticals, Inc. (7)
- SAVIENT PHARMACEUTICALS INC (4)
- SCICLONE PHARMACEUTICALS INC (13)
- Scopus BioPharma Inc. (2)
- scPharmaceuticals Inc. (3)
- SCYNEXIS INC (4)
- SenesTech, Inc. (5)
- Shuttle Pharmaceuticals, Inc. (1)
- Sienna Biopharmaceuticals, Inc. (11)
- SIGA TECHNOLOGIES INC (1)
- Strongbridge Biopharma plc (1)
- Sucampo Pharmaceuticals, Inc. (9)
- Supernus Pharmaceuticals, Inc. (13)
- SYNERGY PHARMACEUTICALS, INC. (1)
- TAPESTRY PHARMACEUTICALS, INC (3)
- Targeted Medical Pharma, Inc. (5)
- Tarsus Pharmaceuticals, Inc. (2)
- Telomir Pharmaceuticals, Inc. (2)
- Tenzing Acquisition Corp. (4)
- Terns Pharmaceuticals, Inc. (8)
- Terra Tech Corp. (7)
- TerrAscend Corp. (1)
- TETRALOGIC PHARMACEUTICALS CORP (4)
- TETRAPHASE PHARMACEUTICALS INC (7)
- TEVA PHARMACEUTICAL INDUSTRIES LTD (19)
- TFF Pharmaceuticals, Inc. (1)
- THAR PHARMACEUTICALS INC (2)
- The Medicines Company (16)
- TherapeuticsMD, Inc. (2)
- Theravance Biopharma, Inc. (9)
- Theseus Pharmaceuticals, Inc. (2)
- Tilray, Inc. (5)
- TILT Holdings Inc. (4)
- TITAN PHARMACEUTICALS INC (7)
- Trevi Therapeutics, Inc. (4)
- Tricida, Inc. (3)
- Trulieve Cannabis Corp. (1)
- Upjohn Inc (8)
- Urigen Pharmaceuticals, Inc. (2)
- Urovant Sciences Ltd. (5)
- VALEANT PHARMACEUTICALS INTERNATIONAL (2)
- Valera Pharmaceuticals Inc (2)
- Vallon Pharmaceuticals, Inc. (8)
- Ventyx Biosciences, Inc. (4)
- Verano Holdings Corp. (4)
- Verona Pharma plc (1)
- Verrica Pharmaceuticals Inc. (4)
- Viamet Pharmaceuticals Holdings LLC (3)
- VION PHARMACEUTICALS INC (2)
- VioQuest Pharmaceuticals, Inc. (2)
- Virpax Pharmaceuticals, Inc. (6)
- Vitae Pharmaceuticals, Inc (4)
- Vitality Biopharma, Inc. (4)
- VIVUS INC (3)
- Wave Life Sciences Ltd. (16)
- Winston Pharmaceuticals, Inc. (1)
- XANODYNE PHARMACEUTICALS INC (4)
- XERIS PHARMACEUTICALS INC (3)
- Zoetis (9)
- ZOGENIX, INC. (11)
- Zynerba Pharmaceuticals, Inc. (12)
- VERANO HOLDINGS CORP. LONG-TERM CASH INCENTIVE PLAN CASH AWARD AGREEMENT (Verano Holdings Corp., Filed With SEC on March 26, 2024)
- VERANO HOLDINGS CORP. LONG-TERM CASH INCENTIVE PLAN (Verano Holdings Corp., Filed With SEC on March 26, 2024)
- Amendment No. 1 to Charlotte's Web Holdings, Inc. Amended 2018 Long-Term Incentive Plan dated April 29, 2021 (Charlotte's Web Holdings, Inc., Filed With SEC on March 21, 2024)
- Verano Holdings Corp. Annual Bonus Plan (Verano Holdings Corp., Filed With SEC on March 15, 2024)
- INCENTIVE WARRANTS TO PURCHASE UP TO 80,000 COMMON SHARES OF TerrAscend Corp. (existing under the laws of Ontario) Void After June _, 2023 (TerrAscend Corp., Filed With SEC on March 14, 2024)
- Form of Non-Qualified Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan (Liquidia Corp, Filed With SEC on March 13, 2024)
- Form of Incentive Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan (Liquidia Corp, Filed With SEC on March 13, 2024)
- Form of Restricted Stock Units Agreement (Performance-Based) under the Liquidia Corporation 2020 Long-Term Incentive Plan (Liquidia Corp, Filed With SEC on March 13, 2024)
- Form of Restricted Stock Units Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan (Liquidia Corp, Filed With SEC on March 13, 2024)
- Liquidia Corporation 2020 Long-Term Incentive Plan (Liquidia Corp, Filed With SEC on March 13, 2024)
- Form of grant notice and restricted stock unit agreement under the Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Longboard Pharmaceuticals, Inc., Filed With SEC on March 12, 2024)
- Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Longboard Pharmaceuticals, Inc., Filed With SEC on March 12, 2024)
- Amended and Restated Annual Bonus Plan (Assertio Holdings, Inc., Filed With SEC on March 11, 2024)
- Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan (OCULAR THERAPEUTIX, INC, Filed With SEC on March 11, 2024)
- Form of Restricted Stock Unit Agreement under 2019 Inducement Stock Incentive Plan (OCULAR THERAPEUTIX, INC, Filed With SEC on March 11, 2024)
- Phathom Pharmaceuticals Inc. 2024 Bonus Plan (Phathom Pharmaceuticals, Inc., Filed With SEC on March 7, 2024)
- Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) under the Amended and Restated 2011 Stock Incentive Plan for grants made prior to February 1, 2022 (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Award Agreement (Employees) under the Amended and Restated 2011 Stock Incentive Plan for grants made prior to February 1, 2022 (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
- Amendment No. 2024-2 to ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan (ANI Pharma Inc, Filed With SEC on February 29, 2024)
- Form of 2024 Performance-Based Restricted Stock Unit Award Agreement (Non-CEO Executive) under the 2020 Incentive Award Plan (Atea Pharmaceuticals, Inc., Filed With SEC on February 28, 2024)
- Form of 2024 Performance-Based Restricted Stock Unit Award Agreement (CEO) under the 2020 Incentive Award Plan (Atea Pharmaceuticals, Inc., Filed With SEC on February 28, 2024)
- Amended and Restated GW Pharmaceuticals plc 2020 Long-Term Incentive Plan (Jazz Pharmaceuticals plc, Filed With SEC on February 28, 2024)
- Amended and Restated 2011 Equity Incentive Plan (approved November 1, 2023) (Jazz Pharmaceuticals plc, Filed With SEC on February 28, 2024)
- Form of RSU Award Grant Notice and RSU Award Agreement under the 2023 Equity Incentive Plan (CymaBay Therapeutics, Inc., Filed With SEC on February 28, 2024)
- Second Amendment to 2022 Inducement Stock Incentive Plan (Fulcrum Therapeutics, Inc., Filed With SEC on February 27, 2024)
- Form of Performance Share Unit Award Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Supernus Pharmaceuticals, Inc., Filed With SEC on February 27, 2024)
- Form of Restricted Stock Unit Award Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Supernus Pharmaceuticals, Inc., Filed With SEC on February 27, 2024)
- Form of Non-Statutory Time-Based Stock Option Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Supernus Pharmaceuticals, Inc., Filed With SEC on February 27, 2024)
- Form of Time-Based Incentive Stock Option Agreement, for awards issued after 2023 under the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Supernus Pharmaceuticals, Inc., Filed With SEC on February 27, 2024)
- 2023 Performance Share Unit terms for grant under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- 2022 Performance Share Unit terms for grant under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Form of stock option terms for 2023 annual non-qualified option grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Performance share unit terms for August 3, 2022 grant to Chirfi Guindo under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Restricted stock unit terms for August 3, 2022 grant to Chirfi Guindo under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Terms for Restricted Stock Unit Grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- 2021 Performance Share Unit terms for grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Form of restricted stock unit terms for 2020 annual grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Form of stock option terms for 2020 annual non-qualified option grants under the Merck & Co., Inc. 2019 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Form of stock option terms for 2019 annual non-qualified option grants under the Merck & Co., Inc. 2010 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)
- Form of stock option terms for 2017 annual non-qualified option grants under the Merck & Co., Inc. 2010 Incentive Stock Plan (Merck, Filed With SEC on February 26, 2024)